{ "@context": "https://schema.org", "@type": "FAQPage", "name": "BioNexus Discovery — Frequently Asked Questions", "url": "https://bionexusdiscovery.com/#faq", "mainEntity": [ { "@type": "Question", "name": "Who can use BioNexus Discovery services?", "acceptedAnswer": { "@type": "Answer", "text": "Our services are designed for academic researchers (MSc and PhD students, postdocs, professors), pharmaceutical companies, biotechnology startups, research institutes, food and environmental labs, and independent scientists worldwide." } }, { "@type": "Question", "name": "Do you work with international clients?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. BioNexus Discovery operates internationally. We collaborate with researchers and organizations across Europe, the Middle East, Africa, and beyond. All project communication can be conducted remotely." } }, { "@type": "Question", "name": "Can you support MSc and PhD research projects?", "acceptedAnswer": { "@type": "Answer", "text": "Absolutely. We regularly support postgraduate research including experimental design, computational analysis, statistical interpretation, figure preparation, and scientific writing for thesis and publication." } }, { "@type": "Question", "name": "What laboratory analyses are available?", "acceptedAnswer": { "@type": "Answer", "text": "We offer HPLC, GC-MS, ICP-MS, ICP-OES, UV-Visible Spectroscopy, ELISA and immunoassays, sample preparation, method development, and method validation — through accredited partner laboratories." } }, { "@type": "Question", "name": "Do you provide publication support?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. We offer end-to-end publication support including scientific writing, statistical analysis, figure and table preparation, journal selection, manuscript formatting, and response to peer reviewer comments." } }, { "@type": "Question", "name": "How do I get started with BioNexus Discovery?", "acceptedAnswer": { "@type": "Answer", "text": "Simply reach out via the contact form, email at info@bionexusdiscovery.com, or WhatsApp at +44 7732 272996. Describe your research needs and we will respond within 24–48 hours with an initial consultation." } }, { "@type": "Question", "name": "What is MultiEndpointTox?", "acceptedAnswer": { "@type": "Answer", "text": "MultiEndpointTox is BioNexus Discovery's proprietary AI-powered computational toxicology platform. It predicts 15+ ADMET and safety endpoints simultaneously from molecular structure using ensemble machine learning (XGBoost, Random Forest, Graph Neural Networks), quantum chemistry descriptors, and SHAP-based explainable AI. Endpoints include hepatotoxicity, cardiotoxicity (hERG), carcinogenicity, mutagenicity, reproductive toxicity, acute oral toxicity (LD50), environmental aquatic toxicity, and regulatory compliance flags (REACH, ICH M7, FDA guidelines)." } }, { "@type": "Question", "name": "What is the typical turnaround time for a computational analysis project?", "acceptedAnswer": { "@type": "Answer", "text": "Turnaround depends on project scope. Simple computational analyses such as molecular docking or toxicology screening typically complete within 3–7 business days. Comprehensive multi-omics studies, full bioinformatics pipelines, or complete publication support projects typically run 2–8 weeks. We provide a clear timeline during the initial consultation." } }, { "@type": "Question", "name": "Do you offer ADMET prediction for drug discovery?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Our MultiEndpointTox platform provides comprehensive ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. This includes oral bioavailability, blood-brain barrier penetration, CYP enzyme inhibition, P-glycoprotein substrate prediction, plasma protein binding, hepatotoxicity, cardiotoxicity, and more." } }, { "@type": "Question", "name": "Can BioNexus Discovery help with RNA-seq data analysis?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. We provide complete RNA-seq analysis pipelines including quality control (FastQC, Trimmomatic), alignment (STAR, HISAT2), differential expression analysis (DESeq2, edgeR), gene ontology and pathway enrichment (KEGG, Reactome, GO), and publication-ready visualizations (volcano plots, heatmaps, PCA)." } }, { "@type": "Question", "name": "What nanoformulation types can you design computationally?", "acceptedAnswer": { "@type": "Answer", "text": "We computationally design and optimize liposomes, PLGA and polymeric nanoparticles, lipid nanoparticles (LNPs), solid lipid nanoparticles (SLNs), dendrimers, chitosan nanoparticles, and inorganic carriers (gold, silica, iron oxide). Our AI-guided approach predicts encapsulation efficiency, particle size, zeta potential, and drug release kinetics." } }, { "@type": "Question", "name": "Do you perform molecular docking and virtual screening?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. We offer structure-based virtual screening, molecular docking (AutoDock Vina, Glide, GOLD), pharmacophore modelling, induced-fit docking, and binding free energy calculations (MM-GBSA/PBSA). We screen compound libraries against validated protein targets and provide ranked hit lists with binding mode analysis." } }, { "@type": "Question", "name": "What microbiology services does BioNexus Discovery offer?", "acceptedAnswer": { "@type": "Answer", "text": "Our industrial microbiology services include fermentation process optimization, antimicrobial resistance (AMR) profiling, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) testing, biofilm formation and inhibition studies, microbiome diversity analysis using 16S rRNA sequencing, plant growth-promoting rhizobacteria (PGPR) screening, biosurfactant research, food microbiology testing, and water safety analysis." } }, { "@type": "Question", "name": "What is green corrosion inhibitor research?", "acceptedAnswer": { "@type": "Answer", "text": "Green corrosion inhibitor research develops plant-derived, biodegradable molecules that protect metals from corrosion without the environmental and health hazards of traditional chemical inhibitors. BioNexus Discovery combines experimental electrochemical testing (EIS, potentiodynamic polarization) with computational molecular screening to identify and optimize green inhibitors from plant extracts for industrial applications." } }, { "@type": "Question", "name": "Does BioNexus Discovery offer protein structure prediction and analysis?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. We use AlphaFold2, RoseTTAFold, and ESMFold for protein structure prediction, followed by structure quality assessment, active site analysis, protein-ligand interaction profiling, and homology modelling for novel protein targets." } }, { "@type": "Question", "name": "Can you help with QSAR model development?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. We develop quantitative structure-activity relationship (QSAR) models using classical regression methods and modern machine learning approaches including Random Forest, XGBoost, and Graph Neural Networks. We follow OECD guidelines for model validation (internal and external validation, applicability domain analysis)." } }, { "@type": "Question", "name": "What is your confidentiality policy for research data?", "acceptedAnswer": { "@type": "Answer", "text": "BioNexus Discovery treats all client data with strict confidentiality. We sign non-disclosure agreements (NDAs) upon request before any project begins. Data is shared only through secure channels and is never disclosed to third parties. Proprietary compound structures, sequences, and research data remain the sole intellectual property of the client." } }, { "@type": "Question", "name": "Do you offer network pharmacology analysis?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. Network pharmacology is a core BioNexus Discovery service. We construct drug-target-disease interaction networks, identify hub genes and pathways, perform target fishing using reverse docking, and integrate protein-protein interaction databases (STRING, BioGRID) with transcriptomic data to reveal polypharmacological mechanisms." } }, { "@type": "Question", "name": "Can you assist with regulatory dossier preparation?", "acceptedAnswer": { "@type": "Answer", "text": "We support regulatory submission preparation by providing computational ADMET and toxicology data packages for FDA, EMA, and ICH guideline compliance. This includes ICH M7 mutagenicity assessment, REACH chemical safety reports, and computational data packages formatted for pre-IND and IND applications." } }, { "@type": "Question", "name": "What materials characterization techniques are available?", "acceptedAnswer": { "@type": "Answer", "text": "Through our partner laboratory network we offer SEM (Scanning Electron Microscopy), EDX (Energy Dispersive X-ray analysis), XRD (X-ray Diffraction), tensile and hardness testing, surface roughness measurement, and contact angle analysis for wettability assessment." } }, { "@type": "Question", "name": "Do you provide bioinformatics training or consultation?", "acceptedAnswer": { "@type": "Answer", "text": "Yes. We offer one-on-one bioinformatics consultation sessions for researchers who want to understand and apply computational biology methods to their own data. Topics include RNA-seq analysis, molecular docking workflows, QSAR modelling, and multi-omics integration. Contact us to arrange a tailored session." } } ] }